GlassScriptPhysician profile
Richard Mermelstein
NPI 1629488440
$3,864.50
in general payments reported to CMS, 2019-2025
31 companies · $789 in 2025
The $789 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $120 · 2022: $565 · 2023: $190 · 2024: $2,015 · 2025: $789.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,780 · Gift: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,779.50 |
| Gift | $215.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $632.98 | 2024-2025 | |
| Medtronic, INC. | $440.00 | 2022 | |
| Sekisui Diagnostics LLC | $340.00 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $244.30 | 2024 | Airsupra, Lokelma, Farxiga |
| Amgen INC. | $223.61 | 2024-2025 | Krystexxa, Repatha, Otezla |
| Ani Pharmaceuticals, INC. | $212.68 | 2024-2025 | Purified Cortrophin Gel |
| Renalytix Ai, INC. | $186.53 | 2024-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Genzyme Corporation | $185.00 | 2019 | |
| Nevro Corp. | $180.28 | 2024 | Senza |
| Lilly USA, LLC | $156.63 | 2024-2025 | Taltz, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $155.14 | 2020-2025 | Shingrix, Arexvy |
| Astellas Pharma US INC | $118.78 | 2024-2025 | Veozah |
| Novo Nordisk INC | $102.68 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Biotech, INC. | $89.63 | 2024-2025 | Tremfya |
| Alexion Pharmaceuticals, INC. | $87.69 | 2024 | Strensiq |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $59.18 | 2025 | Tremfya |
| Mallinckrodt Hospital Products INC. | $57.69 | 2024 | Acthar |
| Pfizer INC. | $53.43 | 2024 | |
| Exact Sciences Corporation | $52.95 | 2025 | The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $43.55 | 2024-2025 | |
| Ucb, INC. | $43.25 | 2024-2025 | Bimzelx |
| Otsuka America Pharmaceutical, INC. | $27.65 | 2024 | Jynarque |
| E.R. Squibb & Sons, L.L.C. | $25.58 | 2024 | Orencia |
| Octapharma USA, INC. | $24.80 | 2024 | Octagam Immune Globulin (Human) |
| Kiniksa Pharmaceuticals International, Plc | $21.18 | 2024 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.01 | 2025 | |
| Aurinia Pharma U.S., INC. | $17.58 | 2024 | Lupkynis |
| Bausch Health US, LLC | $17.16 | 2025 | Aplenzin |
| Sandoz INC. | $15.89 | 2024 | Hyrimoz |
| Opko Pharmaceuticals, LLC | $15.88 | 2024 | Rayaldee |
| Bioventus LLC | $14.79 | 2024 | Supartz Fx Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Mermelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.